151 related articles for article (PubMed ID: 38638185)
1. Assessing the Effectiveness of Stabilized Cysteamine 5% Cream Compared to Hydroquinone 4%/Ascorbic Acid 3% Combination Cream in Treating Acne-induced Post-inflammatory Hyperpigmentation: A Randomized, Controlled Study.
Ahmadi K; Miri A; Bizaval Z; Sepaskhah M; Ranjbar S; Bagheri Z; Kasraee B
J Clin Aesthet Dermatol; 2024 Apr; 17(4):37-41. PubMed ID: 38638185
[TBL] [Abstract][Full Text] [Related]
2. A case report on the use of topical cysteamine 5% cream in the management of refractory postinflammatory hyperpigmentation (PIH) resistant to triple combination cream (hydroquinone, topical corticosteroids, and retinoids).
Mathe N; Balogun M; Yoo J
J Cosmet Dermatol; 2021 Jan; 20(1):204-206. PubMed ID: 32997864
[TBL] [Abstract][Full Text] [Related]
3. Reliability assessment and validation of the postacne hyperpigmentation index (PAHPI), a new instrument to measure postinflammatory hyperpigmentation from acne vulgaris.
Savory SA; Agim NG; Mao R; Peter S; Wang C; Maldonado G; Bearden Dietert J; Lieu TJ; Wang C; Pretzlaff K; Das S; Vandergriff T; Lopez IE; Litzner BR; Hynan LS; Arellano-Mendoza MI; Bergstresser PR; Pandya AG
J Am Acad Dermatol; 2014 Jan; 70(1):108-14. PubMed ID: 24176524
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the efficacy of cysteamine 5% cream and hydroquinone 4%/ascorbic acid 3% combination cream in the treatment of epidermal melasma.
Sepaskhah M; Karimi F; Bagheri Z; Kasraee B
J Cosmet Dermatol; 2022 Jul; 21(7):2871-2878. PubMed ID: 35510765
[TBL] [Abstract][Full Text] [Related]
5. Effects of 15% Azelaic Acid Gel in the Management of Post-Inflammatory Erythema and Post-Inflammatory Hyperpigmentation in Acne Vulgaris.
Shucheng H; Zhou X; Du D; Li J; Yu C; Jiang X
Dermatol Ther (Heidelb); 2024 May; 14(5):1293-1314. PubMed ID: 38734843
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the efficacy of cysteamine cream compared to hydroquinone in the treatment of melasma: A randomised, double-blinded trial.
Nguyen J; Remyn L; Chung IY; Honigman A; Gourani-Tehrani S; Wutami I; Wong C; Paul E; Rodrigues M
Australas J Dermatol; 2021 Feb; 62(1):e41-e46. PubMed ID: 32981068
[TBL] [Abstract][Full Text] [Related]
7. Trichloroacetic acid model to accurately capture the efficacy of treatments for postinflammatory hyperpigmentation.
Lyons AB; Kohli I; Nahhas AF; Braunberger TL; Mohammad TF; Nicholson CL; Nartker NT; Modi K; Matsui MS; Lim HW; Hamzavi IH
Arch Dermatol Res; 2020 Dec; 312(10):725-730. PubMed ID: 32253506
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of 20% azelaic acid cream versus 5% tranexamic acid solution for the treatment of postinflammatory hyperpigmentation in patients with acne vulgaris: A single-blinded randomized clinical trial.
Sobhan M; Talebi-Ghane E; Poostiyan E
J Res Med Sci; 2023; 28():18. PubMed ID: 37213446
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of Jessner's solution peel in comparison with salicylic acid 30% peel in the management of patients with acne vulgaris and postacne hyperpigmentation with skin of color: a randomized, double-blinded, split-face, controlled trial.
How KN; Lim PY; Wan Ahmad Kammal WSL; Shamsudin N
Int J Dermatol; 2020 Jul; 59(7):804-812. PubMed ID: 32447767
[TBL] [Abstract][Full Text] [Related]
10. Topical Stabilized Cysteamine as a New Treatment for Hyperpigmentation Disorders: Melasma, Post-Inflammatory Hyperpigmentation, and Lentigines.
Desai S; Hartman C; Grimes P; Shah S
J Drugs Dermatol; 2021 Dec; 20(12):1276-1279. PubMed ID: 34898155
[TBL] [Abstract][Full Text] [Related]
11. Clinical Comparison of Topical 2.5% Benzoyl Peroxide plus 5% Niacinamide to 2.5% Benzoyl Peroxide Alone in the Treatment of Mild to Moderate Facial Acne Vulgaris.
Kaewsanit T; Chakkavittumrong P; Waranuch N
J Clin Aesthet Dermatol; 2021 Jun; 14(6):35-41. PubMed ID: 34804354
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of cysteamine cream in the treatment of epidermal melasma, evaluating by Dermacatch as a new measurement method: a randomized double blind placebo controlled study.
Farshi S; Mansouri P; Kasraee B
J Dermatolog Treat; 2018 Mar; 29(2):182-189. PubMed ID: 28678558
[TBL] [Abstract][Full Text] [Related]
13. Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: a double-blind, randomized, vehicle-controlled study.
Grimes P; Callender V
Cutis; 2006 Jan; 77(1):45-50. PubMed ID: 16475496
[TBL] [Abstract][Full Text] [Related]
14. Fusidic acid cream comparatively minimizes signs of inflammation and postinflammatory hyperpigmentation after ablative fractional CO
Wei M; Li L; Zhang XF; Li M; Wang B; Yan Y
J Cosmet Dermatol; 2021 Jun; 20(6):1692-1699. PubMed ID: 32979860
[TBL] [Abstract][Full Text] [Related]
15. Hydroquinone therapy for post-inflammatory hyperpigmentation secondary to acne: not just prescribable by dermatologists.
Chandra M; Levitt J; Pensabene CA
Acta Derm Venereol; 2012 May; 92(3):232-5. PubMed ID: 22002814
[TBL] [Abstract][Full Text] [Related]
16. RALGA (Diacneal), a retinaldehyde and glycolic acid association and postinflammatory hyperpigmentation in acne--a review.
Katsambas AD
Dermatology; 2005; 210 Suppl 1():39-45. PubMed ID: 15724107
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of topical 5% cysteamine versus 4% hydroquinone in the treatment of facial melasma in women.
Lima PB; Dias JAF; Cassiano D; Esposito ACC; Bagatin E; Miot LDB; Miot HA
Int J Dermatol; 2020 Dec; 59(12):1531-1536. PubMed ID: 32864760
[TBL] [Abstract][Full Text] [Related]
18. Acne treatment efficacy of intense pulsed light photodynamic therapy with topical licochalcone A, l-carnitine, and decanediol: A spilt-face, double-blind, randomized controlled trial.
Wanitphakdeedecha R; Tavechodperathum N; Tantrapornpong P; Suphatsathienkul P; Techapichetvanich T; Eimpunth S; Manuskiatti W
J Cosmet Dermatol; 2020 Jan; 19(1):78-87. PubMed ID: 31587493
[TBL] [Abstract][Full Text] [Related]
19. Significant therapeutic response to cysteamine cream in a melasma patient resistant to Kligman's formula.
Kasraee B; Mansouri P; Farshi S
J Cosmet Dermatol; 2019 Feb; 18(1):293-295. PubMed ID: 30537063
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of an epidermal growth factor-containing cream on postinflammatory hyperpigmentation after 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser treatment of acquired bilateral nevus of Ota-like macules (Hori's nevus) in Asians: A split-face, double-blinded, randomized controlled study.
Wattanakrai P; Sindhusen S; Ploydaeng M
J Cosmet Dermatol; 2022 May; 21(5):2031-2037. PubMed ID: 35066982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
